These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 12500277
21. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. van den Bos IC, Hussain SM, Dwarkasing RS, Hop WC, Zondervan PE, de Man RA, IJzermans JN, Walker CW, Krestin GP. J Magn Reson Imaging; 2007 Dec; 26(6):1548-55. PubMed ID: 17968956 [Abstract] [Full Text] [Related]
22. Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance. Kanematsu M, Danet MI, Leonardou P, Mastropasqua M, Mosetti MA, Braga L, Woosley JT, Semelka RC. J Magn Reson Imaging; 2004 Aug; 20(2):242-9. PubMed ID: 15269949 [Abstract] [Full Text] [Related]
23. MRI and MRCP findings of the pancreas in patients with diabetes mellitus: compared analysis with pancreatic exocrine function determined by fecal elastase 1. Bilgin M, Balci NC, Momtahen AJ, Bilgin Y, Klör HU, Rau WS. J Clin Gastroenterol; 2009 Feb; 43(2):165-70. PubMed ID: 18797409 [Abstract] [Full Text] [Related]
29. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose. Nural MS, Gokce E, Danaci M, Bayrak IK, Diren HB. Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901 [Abstract] [Full Text] [Related]
31. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators. Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A. Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277 [Abstract] [Full Text] [Related]
32. [Comparison of MRI manifestations and histopathologic findings in pancreatic head carcinoma in vivo ex vivo]. Wang DQ, Zeng MS, Shi X, Ji Y, Jin DY, Lou WH, Chen CZ, Li RC, Shen JZ. Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):347-51. PubMed ID: 18953833 [Abstract] [Full Text] [Related]
35. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. Kim JK, Altun E, Elias J, Pamuklar E, Rivero H, Semelka RC. J Magn Reson Imaging; 2007 Aug; 26(2):313-22. PubMed ID: 17610286 [Abstract] [Full Text] [Related]
36. Bone metastases: evaluation of acuity of lesions using dynamic gadolinium-chelate enhancement, preliminary results. Northam M, de Campos RO, Ramalho M, Heredia V, Gonzalez CA, Azevedo RM, Semelka RC. J Magn Reson Imaging; 2011 Jul; 34(1):120-7. PubMed ID: 21618328 [Abstract] [Full Text] [Related]
37. [Diagnostic efficacy of gadodiamide-enhanced dynamic examination technique in comparison to conventional magnet resonance tomography in exacerbated chronic osteomyelitis]. Rademacher G, Stengel D, Paris S, Cramer J, Mutze S. Rofo; 2003 Oct; 175(10):1417-23. PubMed ID: 14556112 [Abstract] [Full Text] [Related]